Abstract:Emerging evidence suggests that genetic polymorphisms in X-ray repair cross-complementation group 1 (XRCC1) gene could be associated with pancreatic cancer risk. However, previous published studies on the association between XRCC1 rs1799782 genetic polymorphism and pancreatic cancer risk reported inconsistent results. For better understanding of the effects of XRCC1 rs1799782 genetic polymorphism on pancreatic cancer risk, we conducted a meta-analysis of previous published studies by calculating the pooled odds ratio (OR) with a 95 % confidence interval (95 % CI). A total of five eligible studies with 1,144 pancreatic cancer cases and 2,925 controls were eventually enrolled. Overall, we found that the XRCC1 rs1799782 genetic polymorphism was not associated with pancreatic cancer risk in total population under all genetic models (TT vs. CC: OR = 1.11, 95 % CI 0.76-1.63, P = 0.583; CT vs. CC: OR = 1.39, 95 % CI 0.92-2.10, P = 0.118; TT/CT vs. CC: OR = 1.39, 95 % CI 0.92-2.10, P = 0.121; TT vs. CT/CC: OR = 1.07, 95 % CI 0.73-1.55, P = 0.743; T vs. C: OR = 1.31, 95 % CI 0.93-1.86, P = 0.125). In the subgroup analysis based on ethnicity, there was no statistically significant association between XRCC1 rs1799782 genetic polymorphism and pancreatic cancer risk in Asians/Caucasians under all genetic models (all P values > 0.05). No publication bias was detected in this study. Our meta-analysis suggests that the XRCC1 rs1799782 genetic polymorphism is not significantly associated with pancreatic cancer risk. Considering the limited sample size and ethnicity enrolled in this meta-analysis, further larger scaled studies are needed to provide a more precise estimation on the association.

WITHDRAWN: Polymorphisms Rs2073618 and Rs3102735 in TNFRSF11B with the Susceptibility to Gastric Cancer

Polymorphisms Rs2073618 and Rs3102735 in TNFRSF11B with the Susceptibility to Gastric Cancer

WITHDRAWN: Tanshinone II-A, a Putative Modulator Can Regulate Pro-Inflammatory and Anti-Inflammatory Cytokines in Inflammatory Conditions in RAW264.7 Cells

RETRACTION: CYP2E1 Rsa /Pst polymorphism and lung cancer susceptibility: A meta-analysis involving 10,947 subjects (Retraction of Vol 19, Pg 2136, 2015)

WITHDRAWN: Associations of Polymorphisms in CTLA-4 and IL-18 with Liver Diseases: Evidence from a Meta-Analysis

WITHDRAWN: Comparative study of CT appearances in renal carcinoma associated with Xp11.2 translocation/TFE gene fusion and papillary renal cell carcinoma.

WITHDRAWN: Genetic Polymorphisms of Pharmacogenomic VIP Variants in the Wa Population from Southwest China

WITHDRAWN: Common polymorphisms in the MDGA1 gene are associated with bipolar disorder and schizophrenia in the Chinese Han population.

WITHDRAWN: Single Nucleotide Polymorphism, a Putative Driver for the Role of Long Intergeneric Non-Coding RNA.

Null genotypes of GSTM1 and GSTT1 both associated with increased hepatocellular carcinoma risk in Asians: new evidence

Tumor Necrosis Factor-308 Polymorphism with the Risk and Prognosis of Non-Hodgkin Lymphomas: a Meta-Analysis Study [Corrigendum]

Effect of TNF-α rs1800629 a variant mutations on gene expression profiles in multiple trauma patients

WITHDRAWN: (CA) oligonucleotides correct RNA mis-splicing in TDP-43 pathology

WITHDRAWN: Mir-504 Affects the Radio-Resistance in Nasopharyngeal Carcinoma by Down-Regulating the Expression of Nuclear Respiratory Factor 1

WITHDRAWN: CRISPR/Cas9 Mediated HPV and PD1 Inhibition Produces a Synergistic Anti-Tumor Effect on Cervical Cancer.

Retracted: Lack of Association of Xrcc1 Rs1799782 Genetic Polymorphism with Risk of Pancreatic Cancer: A Meta-Analysis (retracted Article. See April, 2017)

WITHDRAWN: The Molecular Signature Associated with Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer

WITHDRAWN: Two distinct structural variants involving EDN3 cause hyperpigmentation in chicken

Retracted: Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells

WITHDRAWN: Clinical Effectiveness of Neoadjuvant Chemotherapy in Advanced Gastric Cancer: an Updated Meta-Analysis of 12 Randomized Controlled Trials.

WITHDRAWN: Two Novel Heterozygous Mutations of CSA Cause Cockayne Syndrome in a Chinese Family.